NAME: SAHIL SINGH
ROLL NO: 21230023646
BATCH: F1
Title: Relationship of Sun Pharmaceutical Industries Ltd. with NIFTY50.
Author: SHUBHAM SINGH
Intro: Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries across the globe.
Objective: Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.
Views and Reviews: Sun Pharma witnessed a mixed bag in terms of financial performance. It reported varying quarterly results, with some quarters showing growth in revenue and profits, while others faced challenges due to pricing pressures in certain markets and increased competition.
The company continued its focus on research and development, launching new products and obtaining approvals for generics and specialty drugs across different markets, including the US and emerging economies. Some of their key products saw strong sales, contributing significantly to their revenue.
Data collection: Nifty and Sun Pharmaceutical Industries Ltd. closing price was collected from NSE website. Weekly return of Nifty is termed as “X” and weekly return is Sun Pharmaceutical Industries Ltd. termed as “Y”. Besides that, a few other things written in this report are taken from other websites and its information is provided in references.
Data Analysis:
Equation: Y= 0.231+ 0.603x
Interpretation:
The above equation shows the relation between Nifty50 and
Return of Sun Pharmaceutical Industries Ltd is dependent variable and return of Nifty50 is independent variable.
Positive sign means if Nifty50 rises by 1 unit then share price of Sun Pharmaceutical Industries Ltd capital will also rise by 0.1557 and vice-versa.
Number of observations are 49.
2.9443 is the t-stat for Y, the p-value for which is 0.005
R square is 0.1557 which means 15% of variances in Sun Pharmaceutical Industries are explained by Nifty.
F is 8.6689, p-value for this is 0.4251 which means model is statistically significant at 1% level.
Conclusion: Beta is 0.02310 which is less than 1, it means that Sun Pharmaceutical Industries is good for long term investment.
Reference:
https://sunpharma.com/